Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation

被引:0
|
作者
S Agrawal
S Koschmieder
N Bäumer
N G P Reddy
W E Berdel
C Müller-Tidow
H Serve
机构
[1] Hematology and Oncology,Department of Medicine
[2] University of Münster,undefined
[3] Medizinische Klinik II,undefined
[4] Johann Wolfgang Goethe Universität,undefined
来源
Leukemia | 2008年 / 22卷
关键词
acute myeloid leukemia; signal transduction; cell cycle regulation; pim kinases; Fms-like tyrosine kinase-3;
D O I
暂无
中图分类号
学科分类号
摘要
Pim2 is a serine/threonine kinase expressed at high levels in several malignancies including acute leukemia. Pim2 protein is induced by oncogenic Fms-like tyrosine kinase-3 (Flt3)-internal tandem duplications (ITD), but not by Flt3 wild-type receptor (Flt3-Wt) in response to Flt3 ligand (FL). Here we show that Pim2 can complement Flt3-Wt signaling and induce transformation similar to Flt3-ITD in myeloid cells. Our data demonstrate that Pim2 is necessary but not sufficient for Flt3-ITD-induced transformation of 32D cells and primary bone marrow cells as assessed by colony assays. Pim2-induced clonogenic growth of FL-treated 32D-Flt3-Wt cells. Proliferation of 32D-Flt3-Wt cells was significantly enhanced in FL-treated Pim2-overexpressing cells. This increase was associated with enhanced S-phase cell cycle progression. Pim2-overexpressing cells were resistant to apoptosis induced by growth factor deprivation or treatment with tyrosine kinase inhibitor (PKC412). The Flt3 point mutant D835Y, which is not able to support colony growth of myeloid cells, also induced clonogenic growth in the presence of Pim2. In conclusion, Pim2 is an important target of Flt3-ITD-induced transformation, and overexpression of Pim2 together with Flt3-Wt or D835Y receptor mimics Flt3-ITD-mediated transformation. Pim2 complements with Flt3-Wt signaling to induce proliferation by enhancing G1/S-phase progression of the cell cycle.
引用
收藏
页码:78 / 86
页数:8
相关论文
共 50 条
  • [1] Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation
    Agrawal, S.
    Koschmieder, S.
    Baeumer, N.
    Reddy, N. G. P.
    Berdel, W. E.
    Mueller-Tidow, C.
    Serve, H.
    LEUKEMIA, 2008, 22 (01) : 78 - 86
  • [2] Novel FLT3 mutation shows dominant negative effects on the wild-type FLT3 receptor
    Bauer, J.
    Sandhoefer, N.
    Hiddemann, W.
    Spiekermann, K.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S121 - S121
  • [3] Novel FLT3 Mutation Shows Dominant Negative Effects on the Wild-Type FLT3 Receptor
    Bauer, Julia
    Sandhoefer, Nadine
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BLOOD, 2014, 124 (21)
  • [4] FL-Dependent Wild-Type FLT3 Signals Reduce the Inhibitory Effects of FLT3 Inhibitors On Wild-Type and Mutant FLT3 Co-Expressing Cells
    Mori, Yumiko
    Kiyoi, Hitoshi
    Ishikawa, Yuichi
    Naoe, Tomoki
    BLOOD, 2009, 114 (22) : 816 - 816
  • [5] p21WAF1/CDKN1 Function In Hematopoietic Progenitor Cell Proliferation Is Inversely Regulated by Wild-Type Flt3 and Internal Tandem Duplication Mutation of Flt3
    Abe, Mariko
    Pelus, Louis M.
    Singh, Pratibha
    Yamaguchi, Seiji
    Taketani, Takeshi
    Fukuda, Seiji
    BLOOD, 2010, 116 (21) : 1699 - 1699
  • [6] The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor
    Sandhoefer, Nadine
    Bauer, Julia
    Reiter, Katrin
    Dufour, Annika
    Rothenberg, Maja
    Konstandin, Nikola P.
    Zellmeier, Evelyn
    Tizazu, Belay
    Greif, Philipp A.
    Metzeler, Klaus H.
    Hiddemann, Wolfgang
    Polzer, Harald
    Spiekermann, Karsten
    SCIENTIFIC REPORTS, 2016, 6
  • [7] The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor
    Nadine Sandhöfer
    Julia Bauer
    Katrin Reiter
    Annika Dufour
    Maja Rothenberg
    Nikola P. Konstandin
    Evelyn Zellmeier
    Belay Tizazu
    Philipp A. Greif
    Klaus H. Metzeler
    Wolfgang Hiddemann
    Harald Polzer
    Karsten Spiekermann
    Scientific Reports, 6
  • [8] Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
    Chen, Fangli
    Ishikawa, Yuichi
    Akashi, Akimi
    Naoe, Tomoki
    Kiyoi, Hitoshi
    ONCOTARGET, 2016, 7 (30) : 47018 - 47032
  • [9] Wild-type FLT3 and FLT3 ITD exhibit similar ligand-induced internalization characteristics
    Kellner, Fabienne
    Keil, Andreas
    Schindler, Katrin
    Tschongov, Todor
    Huenninger, Kerstin
    Loercher, Hannah
    Rhein, Peter
    Boehmer, Sylvia-Annette
    Boehmer, Frank-D.
    Mueller, Joerg P.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (08) : 4668 - 4676
  • [10] Evaluation of Emergent FLT3 Mutations (FLT3m) at Relapse in Patients (Pts) with Wild-Type FLT3 Acute Myeloid Leukemia (AML)
    Haddad, Fadi
    Medawar, Georgio
    Kanagal-Shamanna, Rashmi
    Alvarez, Hector
    Loghavi, Sanam
    Daver, Naval
    Pierce, Sherry A.
    Jabbour, Elias
    Kadia, Tapan M.
    Short, Nicholas
    DiNardo, Courtney D.
    Borthakur, Gautam
    Abbas, Hussein A.
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop
    Yilmaz, Musa
    BLOOD, 2022, 140 : 3196 - 3198